What: An analysis revealed that only 0.8% of 90,000+ drug trials included pregnant participants, leaving a major gap in research.
Key line: “We found only 19 trials for non-infectious chronic conditions…”
Source: JAMA.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
KFF poll finds strong bipartisan opposition to health spending cuts.
Study finds no mass OBGYN flight from states with abortion bans—yet.
DOJ says states can’t overrule FDA—even as future restrictions loom.
Survey shows vast majority of women feel unprepared for menopause.
Maternie analysis shows $31M cut from women’s health research, especially maternal health.
New research finds minor, temporary changes in menstrual cycle length post-vaccine.
Women with endometriosis are more likely to face earlier surgical or natural menopause.
Vox explores new science to delay menopause—and whether we should.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
ACOG proposes fewer but longer prenatal visits to improve care for low-risk pregnancies.
Jess Valenti flags a suspiciously timed study used to attack abortion pill access.
Healthier childhood diets—not body size—linked to later menstruation.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
The Guardian reviews how “fetal personhood” laws could criminalize abortion patients.
Maternie analysis shows $31M cut from women’s health research, especially maternal health.
State attempts to expand fertility coverage face opposition from cost and fetal personhood movements.
A former NIH director calls for institutional changes to better prioritize female health.
Systemic hormones may worsen incontinence; local therapy helps, study says.